药品名称KEFLET
申请号050440产品号003
活性成分CEPHALEXIN市场状态停止上市
剂型或给药途径TABLET;ORAL规格EQ 250MG BASE
治疗等效代码参比药物
批准日期1987/02/26申请机构ELI LILLY AND CO
化学类型审评分类
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
050440045AP1982/09/17Labeling Revision
050440044AP1982/09/17Labeling Revision
050440043AP1982/09/17New Dosage Regimen
050440042AP1982/03/09Control Supplement
050440041AP1981/09/04Labeling Revision
050440040AP1981/02/11Control Supplement
050440039AP1980/12/31Labeling Revision
050440038AP1980/05/12Labeling Revision
050440037AP1980/03/19Formulation Revision
050440036AP1980/03/04Control Supplement
050440035AP1979/11/21Labeling Revision
050440034AP1979/05/21Labeling Revision
050440033AP1979/04/20Control Supplement
050440031AP1979/01/13Labeling Revision
050440030AP1978/11/07New Dosage Regimen
050440029AP1978/05/18Control Supplement
050440028AP1977/05/25Manufacturing Change or Addition
050440027AP1977/03/11Control Supplement
050440026AP1977/02/28Labeling Revision
050440025AP1976/11/02Labeling Revision
050440024AP1976/11/08Expiration Date Change
050440023AP1975/11/17Labeling Revision
050440022AP1975/10/20Formulation Revision
050440021AP1975/06/20Labeling Revision
050440020AP1974/12/27Expiration Date Change
050440019AP1991/07/30Labeling Revision
050440018AP1990/04/10Labeling Revision
050440011AP1986/07/16Labeling Revision
050440009AP1987/01/27Control Supplement
050440008AP1985/11/22Labeling Revision
050440007AP1985/09/06Labeling Revision
050440006AP1984/09/05Control Supplement
050440005AP1983/09/28Labeling Revision
050440004AP1983/09/28Labeling Revision
050440003AP1983/08/15Manufacturing Change or Addition
050440002AP1983/02/15Control Supplement
050440000AP1972/10/12Approval